Persister Resuscitation

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Persister Cells and Infectious Disease

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/978-3-030-25241-0_9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Definitions and guidelines for research on antibiotic persistence

  2019cited by this paper
• ATP-Dependent Dynamic Protein Aggregation Regulates Bacterial Dormancy Depth Critical for Antibiotic Tolerance.

  2019cited by this paper
• Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics.

  2018cited by this paper
• Viable but non‐culturable and persistence describe the same bacterial stress state

  2018cited by this paper
• Shedding light into the mechanisms of formation and resuscitation of persistent bacterial cells.

  2018cited by this paper
• Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells

  2018cited by this paper
• Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease

  2017cited by this paper
• Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders

  2017cited by this paper
• Persistent bacterial infections and persister cells

  2017cited by this paper
• Drug detoxification dynamics explain the postantibiotic effect

  2017cited by this paper
• A General Method for Measuring Persister Levels in Escherichia coli Cultures.

  2016cited by this paper
• Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation

  2016cited by this paper
• Growth resumption from stationary phase reveals memory in Escherichia coli cultures

  2016cited by this paper
• A product of RpfB and RipA joint enzymatic action promotes the resuscitation of dormant mycobacteria

  2015cited by this paper
• Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum

  2015cited by this paper
• Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations

  2014cited by this paper
• The Fatty Acid Signaling Molecule cis-2-Decenoic Acid Increases Metabolic Activity and Reverts Persister Cells to an Antimicrobial-Susceptible State

  2014cited by this paper
• Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics.

  2014cited by this paper
• The phenomenon of microbial uncultivability.

  2013cited by this paper
• Microbial Scout Hypothesis, Stochastic Exit from Dormancy, and the Nature of Slow Growers

  2012cited by this paper
• Proposal for a method to estimate nutrient shock effects in bacteria

  2012cited by this paper
• Growing Unculturable Bacteria

  2012cited by this paper
• Microbial culturomics: paradigm shift in the human gut microbiome study.

  2012cited by this paper
• Resuscitation of Escherichia coli VBNC cells depends on a variety of environmental or chemical stimuli

  2011cited by this paper
• Age of Inoculum Strongly Influences Persister Frequency and Can Mask Effects of Mutations Implicated in Altered Persistence

  2011cited by this paper
• Selective Killing of Bacterial Persisters by a Single Chemical Compound without Affecting Normal Antibiotic-Sensitive Cells

  2011cited by this paper
• Persisting clones of Escherichia coli isolates from recurrent urinary tract infection in men and women.

  2011cited by this paper
• Bet hedging or not? A guide to proper classification of microbial survival strategies

  2011cited by this paper
• Metabolite-Enabled Eradication of Bacterial Persisters by Aminoglycosides

  2011cited by this paper
• The epidemiology of urinary tract infection

  2010cited by this paper
• Persistence of Uropathogenic Escherichia coli in the Face of Multiple Antibiotics

  2010cited by this paper
• Automated imaging with ScanLag reveals previously undetectable bacterial growth phenotypes

  2010cited by this paper
• The Frequency of Persisters in Escherichia coli Reflects the Kinetics of Awakening from Dormancy

  2010cited by this paper
• Microbial awakenings

  2009cited by this paper
• Isolation and Characterization of Superdormant Spores of Bacillus Species

  2009cited by this paper
• Single-Cell and Population Lag Times as a Function of Cell Age

  2008cited by this paper
• A eukaryotic-like Ser/Thr kinase signals bacteria to exit dormancy in response to peptidoglycan fragments.

  2008cited by this paper
• How Bacteria Consume Their Own Exoskeletons (Turnover and Recycling of Cell Wall Peptidoglycan)

  2008cited by this paper
• Microbial phenotypic heterogeneity and antibiotic tolerance.

  2007cited by this paper
• Diabetes and Digestive and Kidney Diseases grants R01 DK051406 and

  2007cited by this paper
• Muralytic activity of Micrococcus luteus Rpf and its relationship to physiological activity in promoting bacterial growth and resuscitation

  2006cited by this paper
• Increased Persistence in Escherichia coli Caused by Controlled Expression of Toxins or Other Unrelated Proteins

  2006cited by this paper
• Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract

  2006cited by this paper
• Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems.

  2005cited by this paper
• A novel firmicute protein family related to the actinobacterial resuscitation-promoting factors by non-orthologous domain displacement

  2005cited by this paper
• Effects of temperature on detection of plasmid or chromosomally encoded gfp- and lux-labeled Pseudomonas fluorescens in soil.

  2004cited by this paper
• Bacterial Persistence as a Phenotypic Switch

  2004cited by this paper
• In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.

  2004cited by this paper
• The uncultured microbial majority.

  2003cited by this paper
• Establishment of a Persistent Escherichia coli Reservoir during the Acute Phase of a Bladder Infection

  2001cited by this paper
• A bacterial cytokine.

  1998cited by this paper
• Viable but non-culturable Vibrio cholerae O1 revert to a cultivable state in the human intestine

  1996cited by this paper
• Rapid assessment of physiological status in Escherichia coli using fluorescent probes.

  1995cited by this paper
• Entry into, and resuscitation from, the viable but nonculturable state by Vibrio vulnificus in an estuarine environment

  1995cited by this paper
• Pharmacokinetic Contributions to Postantibiotic Effects

  1994cited by this paper
• The post-antibiotic effect.

  1993cited by this paper
• Recovery of viable but non-culturable Campylobacter jejuni.

  1991cited by this paper
• Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa

  1989cited by this paper
• A new medium for the enumeration and subculture of bacteria from potable water

  1985cited by this paper
• Simultaneous determination of the total number of aquatic bacteria and the number thereof involved in respiration

  1978cited by this paper

• No citing papers are available for this paper.